000 01428 a2200397 4500
005 20250513125156.0
264 0 _c19971002
008 199710s 0 0 eng d
022 _a0002-9343
024 7 _a10.1016/s0002-9343(97)90029-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSeeman, E
245 0 0 _aOsteoporosis: trials and tribulations.
_h[electronic resource]
260 _bThe American journal of medicine
_cAug 1997
300 _a74S-87S; discussion 87S-89S p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlendronate
_xtherapeutic use
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aCalcitonin
_xtherapeutic use
650 0 4 _aCalcium, Dietary
_xtherapeutic use
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aEtidronic Acid
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFluorides
_xtherapeutic use
650 0 4 _aFractures, Bone
_xetiology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOsteoporosis
_xcomplications
650 0 4 _aOsteoporosis, Postmenopausal
_xdrug therapy
650 0 4 _aParathyroid Hormone
_xtherapeutic use
650 0 4 _aVitamin D
_xtherapeutic use
773 0 _tThe American journal of medicine
_gvol. 103
_gno. 2A
_gp. 74S-87S; discussion 87S-89S
856 4 0 _uhttps://doi.org/10.1016/s0002-9343(97)90029-2
_zAvailable from publisher's website
999 _c9281217
_d9281217